Albert Maguire examines the eyes of gene-therapy patient Misa Kaabali, 8, at the Children’s Hospital of Philadelphia, October 2017. Kaabali received Luxturna, which treats a form of hereditary blindness and was the first gene therapy approved by the FDA.